Exencial Wealth Advisors, LLC Incyte Corp Transaction History

Exencial Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $247,513 - $311,093	-3,740 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $33,076 - $39,934	501 Added 15.47%	3,740 $297,000
Q4 2021 Feb 10, 2022	BUY	$63.34 - $74.11 $18,495 - $21,640	292 Added 9.91%	3,239 $238,000
Q3 2021 Nov 04, 2021	BUY	$68.67 - $84.02 $202,370 - $247,606	2,947 New	2,947 $203,000

617

215M

366K

445K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.